Trial Profile
Comparative study of efficacy and safety of Structum and Chondrosulf in patients with symptomatic osteoarthritis of the knee: a multicentre, randomised, double-blind, double placebo-controlled, parallel group study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2019
Price :
$35
*
At a glance
- Drugs Chondroitin sulfate (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Pierre Fabre
- 12 May 2019 Trial completed in France. (17 Jun 2009)
- 27 Jun 2012 Lead trial centre identified as reported by EudraCT.
- 05 Nov 2010 New trial record.